一项评估brentuximab vedotin联合环磷酰胺、阿霉素、依托泊苷和强的松(BV-CHEP)治疗侵袭性成人t细胞白血病/淋巴瘤的多中心试点研究的最终结果。

IF 3.8 2区 医学 Q1 HEMATOLOGY
Christopher Dittus, Matthew J. Weinstock, Jeffrey Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Kelly Hoye, Anthony Shelton, Xianming Tan, Maya D. Srinivasan, Areej El-Jawahri, Shayna Sarosiek, J. Mark Sloan
{"title":"一项评估brentuximab vedotin联合环磷酰胺、阿霉素、依托泊苷和强的松(BV-CHEP)治疗侵袭性成人t细胞白血病/淋巴瘤的多中心试点研究的最终结果。","authors":"Christopher Dittus, Matthew J. Weinstock, Jeffrey Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Kelly Hoye, Anthony Shelton, Xianming Tan, Maya D. Srinivasan, Areej El-Jawahri, Shayna Sarosiek, J. Mark Sloan","doi":"10.1111/bjh.20177","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":"207 1","pages":"299-303"},"PeriodicalIF":3.8000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma\",\"authors\":\"Christopher Dittus, Matthew J. Weinstock, Jeffrey Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Kelly Hoye, Anthony Shelton, Xianming Tan, Maya D. Srinivasan, Areej El-Jawahri, Shayna Sarosiek, J. Mark Sloan\",\"doi\":\"10.1111/bjh.20177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":135,\"journal\":{\"name\":\"British Journal of Haematology\",\"volume\":\"207 1\",\"pages\":\"299-303\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Haematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bjh.20177\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bjh.20177","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。

Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma

Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.60
自引率
4.60%
发文量
565
审稿时长
1 months
期刊介绍: The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信